Study to Evaluate Sotagliflozin in Subjects With Varying Degrees of Renal Function

Summary

The purpose of this study is to evaluate the effect of mild, moderate, or severe renal impairment, or end-stage renal disease (ESRD) requiring hemodialysis (HD), on the safety and tolerability of 1 or 2 single doses of sotagliflozin compared with healthy, demographically-matched subjects with normal renal function.

Timeline

Start

2015-12

Primary completion

2017-09

Completion

2017-09

Drugs

Indications